These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Implication of the myokine irisin in maternal energy homeostasis in pregnancies with abnormal fetal growth. Briana DD; Boutsikou M; Athanasopoulos N; Marmarinos A; Gourgiotis D; Malamitsi-Puchner A J Matern Fetal Neonatal Med; 2016 Nov; 29(21):3429-33. PubMed ID: 26735968 [TBL] [Abstract][Full Text] [Related]
5. Fetal concentrations of the growth factors TGF-α and TGF-β1 in relation to normal and restricted fetal growth at term. Briana DD; Liosi S; Gourgiotis D; Boutsikou M; Marmarinos A; Baka S; Hassiakos D; Malamitsi-Puchner A Cytokine; 2012 Oct; 60(1):157-61. PubMed ID: 22732125 [TBL] [Abstract][Full Text] [Related]
6. Copeptin: a marker for stress reaction in fetuses with intrauterine growth restriction. Burkhardt T; Schwabe S; Morgenthaler NG; Natalucci G; Zimmermann R; Wellmann S Am J Obstet Gynecol; 2012 Dec; 207(6):497.e1-5. PubMed ID: 23089587 [TBL] [Abstract][Full Text] [Related]
7. Perinatal changes of plasma resistin concentrations in pregnancies with normal and restricted fetal growth. Briana DD; Boutsikou M; Baka S; Gourgiotis D; Marmarinos A; Hassiakos D; Malamitsi-Puchner A Neonatology; 2008; 93(3):153-7. PubMed ID: 17878741 [TBL] [Abstract][Full Text] [Related]
8. Cord blood irisin at the extremes of fetal growth. Baka S; Malamitsi-Puchner A; Boutsikou T; Boutsikou M; Marmarinos A; Hassiakos D; Gourgiotis D; Briana DD Metabolism; 2015 Nov; 64(11):1515-20. PubMed ID: 26307660 [TBL] [Abstract][Full Text] [Related]
9. Effect of intrauterine growth pattern on serum visfatin concentrations in full-term infants at birth and at 6 months of life. El Shemi MS; Mohamed MH; AbdelRahman AO; Abdel Al H; Ramadan NM J Neonatal Perinatal Med; 2016; 9(1):73-82. PubMed ID: 27002258 [TBL] [Abstract][Full Text] [Related]
10. The potential role of the lectin pathway of complement in the host defence of full-term intrauterine growth restricted neonates at birth. Briana DD; Liosi S; Gourgiotis D; Boutsikou M; Baka S; Marmarinos A; Hassiakos D; Malamitsi-Puchner A J Matern Fetal Neonatal Med; 2012 May; 25(5):531-4. PubMed ID: 22082351 [TBL] [Abstract][Full Text] [Related]
11. Soluble fas antigen and soluble fas ligand in intrauterine growth restriction. Briana DD; Baka S; Boutsikou M; Liosi S; Vraila VM; Gourgiotis D; Hassiakos D; Malamitsi-Puchner A Neonatology; 2010; 97(1):31-5. PubMed ID: 19590243 [TBL] [Abstract][Full Text] [Related]
12. Omentin-1 and vaspin are present in the fetus and neonate, and perinatal concentrations are similar in normal and growth-restricted pregnancies. Briana DD; Boutsikou M; Baka S; Gourgiotis D; Marmarinos A; Liosi S; Hassiakos D; Malamitsi-Puchner A Metabolism; 2011 Apr; 60(4):486-90. PubMed ID: 20488498 [TBL] [Abstract][Full Text] [Related]
17. Circulating osteoprotegerin and sRANKL concentrations in the perinatal period at term. The impact of intrauterine growth restriction. Briana DD; Boutsikou M; Baka S; Hassiakos D; Gourgiotis D; Malamitsi-Puchner A Neonatology; 2009; 96(2):132-6. PubMed ID: 19365143 [TBL] [Abstract][Full Text] [Related]